Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chubb
Merck
Fuji
Daiichi Sankyo
Harvard Business School
Chinese Patent Office
Boehringer Ingelheim
McKinsey

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,020,001

« Back to Dashboard

Summary for Patent: 6,020,001
Title: Compositions for treating migraine
Abstract:A pharmaceutical composition for oral adminstration comprising a film-coated solid dosage form including 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide or a pharmaceutically acceptable salt or solvate thereof as active ingredient. The film-coated solid dosage forms are of use in the treatment of conditions associated with cephalic pain, in particular migraine.
Inventor(s): Phillips; Anthony John (Ware, GB), Winterborn; Ian Keith (North Mississauga, CA), Padfield; John Malcolm (Middlesex, GB)
Assignee: Glaxo Group Limited (Greenford, GB)
Application Number:09/121,530
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use; Process;

Drugs Protected by US Patent 6,020,001

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,020,001

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9104890Mar 08, 1991
PCT/EP92/00460Mar 02, 1992

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Healthtrust
Accenture
US Department of Justice
Fuji
Federal Trade Commission
Daiichi Sankyo
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.